Clinical Trials Browser

Phase 1/2 × INDUSTRY × ASTX-660 × Clear all

NCT02503423 2025-01-07

Phase 1-2 Study of ASTX660 in Subjects With Advanced Solid Tumors and Lymphomas

Phase 1/2 Active not recruiting

GynecologicHead & NeckLymphoid

Squamous Cell Carcinoma of Head and Neck, Uterine Cervical Neoplasms, Lymphoma